This article explores key questions on how Medical Affairs teams manage patient engagement across different-sized companies who have variations in focus, resources, and scale.
Getting the most impact from a publication requires being able to define who the audience is and how to reach them, across both journals and online channels, especially in complex/niche cases. In this podcast, we discuss the benefits of taking an analytical approach.
By the end of this webinar, attendees should...
1. Be able to articulate why it’s important to consider a patient community audience when planning scientific and data dissemination including incorporating their voice within it.
2. Be confident to follow clear methodologies to incorporate the patient voice within publications and the role of Medical Affairs in disease awareness campaigns.
3. Be able to implement best practice approaches including novel ways to disseminate information.
This e-Learning module will enable learners to define principles of and adopt an integrated approach to orchestrating omnichannel Company-led Education, identify stakeholder segmentation and associated learning journeys for use in content development, use the associated outcomes and insights to deliver and improve omnichannel medical education, while complying with industry regulations as well as company governance and oversight policies.
Through our lens into real-world issues that affect equitable use of industry innovations, Medical Affairs can drive the transformation of industry from a drug-centric perspective to a patient-centric perspective. This article discusses a few of these opportunities.
This webinar will focus on the role of Medical Affairs to lead patient engagement in clinical development.
Health literacy is experiencing new challenges, and Medical Affairs is uniquely positioned to lead and partner with others in this space to ensure coordination, credibility and impact.
MEDICAL AFFAIRS: The Roles, Value and Practice of Medical Affairs in the Biopharmaceutical and Medical Technology Industries (Taylor & Francis, 2024)
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations.
The MAPS Patient Centricity FAWG surveyed Medical Affairs community, including MAPS members, for their input on patient centricity initiatives within their respective organizations. We will be sharing insights from the recent MAPS Patient Centricity Survey on industry perspectives, including the major barriers to implementing initiatives that were identified in the survey. Our experts will be providing guidance and potential solutions on addressing major barriers for patient centricity initiatives identified through the survey.